Clinical Trials Directory

Trials / Completed

CompletedNCT06228911

Increased Blood Glucose Levels After Steroid Injection

Increased Blood Glucose Levels After Steroid Injection Into Osteoarthritic Knee in Diabetic Patients' Type 2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
600 (actual)
Sponsor
Syrian Private University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

a sample of 600 patients diagnosed as Knee osteoarthritis injected with 40 mg triamcinolone, recorded their morning fasting blood glucose levels for 7 days before injection used as the baseline blood glucose level, which was compared with FBS levels for 14 days after steroid injection. Our study compared the differences in blood glucose changes between HbA1c \>7% and HbA1c ≤7% groups and those between insulin and non-insulin treated groups.

Conditions

Interventions

TypeNameDescription
DRUGsteroid (triamcinolone)triamcinolone is a synthetic corticosteroid medication used topically to treat various skin conditions, to relieve the discomfort of mouth sores, and by injection into joints to treat various joint conditions

Timeline

Start date
2020-01-15
Primary completion
2023-09-15
Completion
2023-09-15
First posted
2024-01-29
Last updated
2024-01-30

Locations

1 site across 1 country: Syria

Source: ClinicalTrials.gov record NCT06228911. Inclusion in this directory is not an endorsement.